| Literature DB >> 16510062 |
Dana Nadalo1, Cathy Montoya, Dan Hunter-Smith.
Abstract
After clinical diagnosis and microscopic confirmation, tinea cruris is best treated with a topical allylamine or an azole antifungal (strength of recommendation: A, based on multiple randomized controlled trials [RCTs]). Differences in current comparison data are insufficient to stratify the 2 groups of topical antifungals. Determining which group to use depends on patient compliance, medication accessibility, and cost. The fungicidal allylamines (naftifine and terbinafine) and butenafine (allylamine derivative) are a more costly group of topical tinea treatments, yet they are more convenient as they allow for a shorter duration of treatment compared with fungistatic azoles (clotrimazole, econazole, ketoconazole, oxiconazole, miconazole, and sulconazole).Entities:
Mesh:
Substances:
Year: 2006 PMID: 16510062
Source DB: PubMed Journal: J Fam Pract ISSN: 0094-3509 Impact factor: 0.493